Page last updated: 2024-08-21

3-hydroxyflavone and Weight Reduction

3-hydroxyflavone has been researched along with Weight Reduction in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (33.33)18.2507
2000's1 (33.33)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bertoia, ML; Cassidy, A; Hu, FB; Mukamal, KJ; Rimm, EB; Willett, WC1
Chrubasik, C; Chrubasik, S; Dawid, C; Hofmann, T; Maier, T; Schieber, A; Torda, T1
Bast, A; Boven, E; Grimbergen, JA; Kramer, K; Kuiper, K; van Acker, SA; van den Berg, DJ; van der Vijgh, WJ1

Reviews

1 review(s) available for 3-hydroxyflavone and Weight Reduction

ArticleYear
Dietary flavonoid intake and weight maintenance: three prospective cohorts of 124,086 US men and women followed for up to 24 years.
    BMJ (Clinical research ed.), 2016, Jan-28, Volume: 352

    Topics: Adult; Diet Records; Feeding Behavior; Female; Flavanones; Flavones; Flavonoids; Flavonols; Follow-Up Studies; Health Personnel; Humans; Life Style; Male; Obesity; Prospective Studies; Risk Factors; Self Report; Time Factors; United States; Weight Gain; Weight Loss

2016

Trials

1 trial(s) available for 3-hydroxyflavone and Weight Reduction

ArticleYear
An observational study and quantification of the actives in a supplement with Sambucus nigra and Asparagus officinalis used for weight reduction.
    Phytotherapy research : PTR, 2008, Volume: 22, Issue:7

    Topics: Anthocyanins; Asparagus Plant; Blood Pressure; Body Weight; Coumaric Acids; Dietary Supplements; Emotions; Flavonols; Fruit; Glycosides; Health Status; Obesity; Phytotherapy; Plant Extracts; Prospective Studies; Quality of Life; Sambucus nigra; Saponins; Weight Loss

2008

Other Studies

1 other study(ies) available for 3-hydroxyflavone and Weight Reduction

ArticleYear
Monohydroxyethylrutoside, a dose-dependent cardioprotective agent, does not affect the antitumor activity of doxorubicin.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 1997, Volume: 3, Issue:10

    Topics: Animals; Antibiotics, Antineoplastic; Antioxidants; Breast Neoplasms; Cardiomyopathies; Catechin; Chelation Therapy; Cystadenocarcinoma, Serous; Dose-Response Relationship, Drug; Doxorubicin; Drug Interactions; Electrocardiography; Female; Flavonoids; Flavonols; Free Radical Scavengers; Free Radicals; Humans; Hydroxyethylrutoside; Iron; Iron Chelating Agents; Kaempferols; Mice; Mice, Nude; Molecular Structure; Neoplasm Transplantation; Ovarian Neoplasms; Quercetin; Razoxane; Rutin; Telemetry; Tumor Cells, Cultured; Weight Loss

1997